Drugs / amino acid (15) peritoneal dialysis solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06597201 | Aug 2024 → Jun 2025 overdue | end stage renal failure | Chengdu Qingshan Likang Pharmaceutical Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amino acid (15) peritoneal dialysis solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06597201 ↗ |